FDA Wants Pharma to Modernize Drug Making

The process of biopharmaceutical drug manufacturing is stuck in the past. And the Food and Drug Administration (FDA) is now openly calling for drugmakers to spring it forward into the 21st century.

In an FDA blog post from earlier this week, Dr. Lawrence Yu compared the predominant “batch” manufacturing technique used by the industry to an archaic relic, particularly in the era of biotech therapies.